GB-0669
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB-0669, covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants [Phase 1]